Radiotherapy with 15 × 2.633 Gy vs. 20 × 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 Trial
Authors:
- Dirk RadesDirk Rades
- Darejan LomidzeDLDarejan Lomidze
- Natalia JankarashviliNJNatalia Jankarashvili
- Fernando Lopez CamposFCFernando Lopez Campos
- Arturo Navarro-MartinANArturo Navarro-Martin
- Barbara SegedinBSBarbara Segedin
- Blaz GroseljBGBlaz Groselj
- Christian StaackmannCSChristian Staackmann
- Nathan Y. YuNYNathan Y. Yu
- Jon CacicedoJCJon Cacicedo
Open Access
Abstract
Many patients with malignant spinal cord compression (MSCC) who are not candidates for neurosurgery receive radiotherapy alone. This study compared 15 × 2.633 Gy over three weeks to 20 × 2.0 Gy over four weeks in patients with favorable survival prognoses. The outcomes of 34 patients treated with 15 × 2.633 Gy (equivalent dose 41.6 Gy10) in the RAMSES-01 trial were compared to 239 patients from an existing database receiving 20 × 2.0 Gy using propensity-score-adjusted Cox and logistic regression models. All patients had favorable survival prognoses. Endpoints included local progression-free survival (LPFS), improvement of motor function, post-treatment ambulatory status, and overall survival (OS). After propensity score adjustment, the 12-month rates of LPFS and OS were 98.1% (RAMSES-01 cohort) vs. 91.6% (p = 0.265) and 79.1% vs. 82.2% (p = 0.704), respectively. Regarding improvement of motor function, 15 × 2.633 Gy appeared superior (p = 0.073). No significant difference was observed regarding ambulatory status (p = 0.822). The three-week regimen for MSCC has similar outcomes and reduces treatment time when compared to a four-week regimen.Keywords
Funding Information
- European Regional Development Fund
This publication has 38 references indexed in Scilit:
- Phase 2 Clinical Trial of Separation Surgery Followed by Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord CompressionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic CancerJAMA, 2019
- Phase 1/2 trial of single‐session stereotactic body radiotherapy for previously unirradiated spinal metastasesCancer, 2012
- Update of the International Consensus on Palliative Radiotherapy Endpoints for Future Clinical Trials in Bone MetastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Dose escalation of radiotherapy for Metastatic Spinal Cord Compression (MSCC) in patients with relatively favorable survival prognosisStrahlentherapie und Onkologie, 2011
- Final Results of a Prospective Study Comparing the Local Control of Short-Course and Long-Course Radiotherapy for Metastatic Spinal Cord CompressionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30Gy in 10 fractions compared with 8Gy in single fractionRadiotherapy and Oncology, 2008
- The first score predicting overall survival in patients with metastatic spinal cord compressionCancer, 2007
- Randomized trial of 8Gy in 1 versus 20Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05)Radiotherapy and Oncology, 2005
- Dose fractionation, dose rate and iso-effect relationships for normal tissue responsesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982